Regulatory flexibility can make continuous improvement possible.
Lois Atkins
Advertisement
Lois Atkins is a principal consultant, CMC regulatory affairs at Eli Lilly and Company
Articles by Lois Atkins
First in a three-part series that discusses the complexities of QbD implementation in biotech product development.
Advertisement
Latest Updated Articles
Quality by Design for Biotechnology Products—Part 3Published: January 1st 2010 | Updated:
Quality by Design for Biotechnology Products—Part 1Published: November 1st 2009 | Updated:
Advertisement
Advertisement
